Ex-Stryker CEO to head disinfectant firm

Eight months after his abrupt resignation from Stryker ($SYK), Stephen MacMillan has landed a job as the CEO of sBioMed, an Orem, UT, maker of clinical anti-infection agents. In an interview with Mass Device, MacMillan described his very public exit from Stryker as "unfair, unfortunate and personally challenging," but said he's enthusiastic to start at sBioMed, which is scaling up commercialization of its Steriplex SD solution. Release | Interview

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.